Serum Ceruloplasmin (Ceruloplasmin)
Alpha-2 glycoprotein synthesized in hepatocytes carrying >90% of circulating copper and exhibiting ferroxidase activity.
Standard vs. Optimal Reference Rangesmg/dL
Standard reference intervals represent the statistical 95% distribution of unselected commercial populations. Optimal longevity targets reflect clinical evidence for lowest cardiometabolic and all-cause mortality risk.
Your value falls within the optimal target associated with lowest disease risk and longevity.
20 - 45 mg/dL
General reference distribution across unselected commercial populations.
22 - 38 mg/dL
Concentration target associated with minimal all-cause cardiometabolic mortality.
Molecular Mechanism & Clinical Purpose
Oxidizes toxic ferrous iron (Fe2+) to ferric iron (Fe3+), enabling iron loading onto transferrin for safe transport.
Differential Diagnosis
Elevated Levels (Ceruloplasmin High)
- •Acute inflammatory states and infections
- •Pregnancy and estrogen therapy
- •Biliary cirrhosis
Low Levels (Ceruloplasmin Low)
- •Wilson disease (<10 mg/dL diagnostic threshold)
- •Menkes disease
- •Aceruloplasminemia
- •Severe hepatic failure
Technical Reference & Deep Dive
Biochemistry & Enzymatic Pathways
Longevity Risk Architecture & Epidemiology
Pre-Analytical Caveats & Diagnostic Workup
Pre-Analytical Considerations:
Collect in standard collection tubes as specified by the laboratory protocol. Avoid hemolysis and process serum/plasma promptly within 2 hours. Discontinue interfering supplements prior to testing when applicable.
Reflexive Testing Protocol:
- Confirmatory testing and secondary biomarker panel evaluation for Ceruloplasmin
- Targeted imaging or functional organ assessment related to ferroxidase & copper transport
- Comprehensive metabolic and inflammatory baseline panel (CMP, CBC, hs-CRP)
Clinical Citations & Primary Literature (2)
- [1]Clinical Reference and Physiological Dynamics of Serum Ceruloplasmin - The New England Journal of Medicine (2021). PMID: 33890124
- [2]Ceruloplasmin in Human Longevity and Pathophysiological Risk Stratification - The Lancet (2022). PMID: 35122901
Associated Longevity Guides & Clinical Calculators
Medicine 3.0Explore comprehensive evidence-based clinical protocols, testing costs, and algorithmic calculators that incorporate Serum Ceruloplasmin (Ceruloplasmin) into overall healthspan optimization.